The global infusion therapy market was valued at USD 49.58 billion in 2024 and is projected to reach USD 83.10 billion by 2034, growing at a CAGR of 5.30% (2025β2034).
The market is fueled by the rising number of cancer and chronic disease patients requiring drip-based drug delivery, coupled with expansion of home healthcare services and technological innovations in infusion devices.
Infusion therapy refers to the administration of medicinal drugs or fluids via a catheter or needle when oral intake is not possible or effective.
Primary method: Intravenous (IV) delivery
Other methods: Subcutaneous, intramuscular, and epidural therapies
Applications include:
Cancer treatment (chemotherapy)
Autoimmune disorders (lupus, rheumatoid arthritis, Crohnβs disease)
Antibiotic/antiviral therapies
Pain management & hydration
Parenteral nutrition
With the increasing burden of cancer, diabetes, and chronic illnesses, infusion therapy is emerging as a critical enabler of advanced patient care.
Access a Sample Report with Full TOC and Figures @ https://www.zionmarketresearch.com/sample/infusion-therapy-market
Market Size 2024: USD 49.58 Billion
Forecast 2034: USD 83.10 Billion
CAGR: 5.30% (2025β2034)
Leading Segment (Type): Infusion Pumps (50%+ revenue share in 2024)
Top Application: Antibiotic/Antiviral Therapy (~31% share in 2024)
Dominant Region: North America (37% market share in 2024)
Infusion therapy ensures controlled and effective drug delivery, vital for chemotherapy and biologics.
Increasing prevalence of cancer, autoimmune diseases, and severe infections is fueling market demand.
Infusion therapy enables targeted drug delivery directly into the bloodstream, improving treatment efficacy.
Growing adoption of at-home infusion therapy for convenience and reduced hospital costs.
Example: The 21st Century Cures Act (US) introduced Medicare coverage for home infusion services.
Personalized care and remote monitoring create new revenue channels for providers.
Complications include:
Air embolism
Infection
Collapsed veins
Allergic reactions (nausea, headache, fever)
Needle insertion challenges, especially in elderly and pediatric patients, may limit adoption.
Integration of IoT and AI-powered infusion pumps for real-time monitoring and dosage precision.
FDA approvals accelerating innovation:
ICU Medical (Apr 2025) β Approval for Plum Solo & Duo pumps with advanced safety software.
Supernus Pharmaceuticals (Feb 2025) β FDA approval for ONAPGO, the first subcutaneous apomorphine infusion for Parkinsonβs disease.
These innovations reduce errors and enhance patient outcomes.
Lack of standard insurance coverage for infusion therapies across regions.
Rising medical waste from disposable infusion devices, raising environmental concerns.
Held 37% of revenue in 2024, driven by a strong healthcare system and high FDA approval rate.
US dominates due to advanced infrastructure and high chronic disease prevalence.
Rising elderly population and comprehensive insurance coverage drive growth.
High demand for cancer and autoimmune infusion therapies.
Strong growth in India, China, Japan, and South Korea.
Key factors:
Expanding cancer-care facilities
Rising accidents requiring IV therapies
Growing healthcare investments
LATAM: Expanding access to modern treatments, led by Brazil & Mexico.
MEA: GCC countries investing in specialty infusion centers and advanced hospital infrastructure.
Key players shaping the market:
Terumo Corporation
Baxter International Inc.
Fresenius Kabi AG
Option Care Health Inc.
Amgen Inc.
B. Braun Melsungen AG
Coam CVS Specialty Infusion Services
Smiths Medical
Eli Lilly and Company
BD (Becton, Dickinson and Company)
Nipro Corporation
ICU Medical Inc.
InfuSystem Holdings Inc.
CareCentrix Inc.
Pfizer Inc.
By Type
Infusion Pumps (dominant)
Needleless Connectors
IV Sets
IV Solutions
IV Cannulas
By Application
Antibiotic/Antiviral Therapy (largest share)
Chemotherapy
Pain Management
Hydration Therapy
Parenteral Nutrition (fastest growing)
Diabetes & Others
By Region
North America (U.S., Canada)
Europe (Germany, UK, France, Spain, Italy, Rest of Europe)
Asia Pacific (China, India, Japan, South Korea, Southeast Asia, Rest of APAC)
Latin America (Brazil, Mexico, Rest of LATAM)
Middle East & Africa (GCC, South Africa, Rest of MEA)
π‘ Home Infusion Growth β Personalized & remote patient care rising
π€ AI & IoT Pumps β Smart monitoring for error-free dosage
π΄ Aging Demographics β Higher need for IV therapies among seniors
π± Eco-Friendly Push β Focus on reducing medical waste